fluorobenzenes has been researched along with Renal Insufficiency in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albertson, TE; Bernard, GR; Brower, RG; deBoisblanc, BP; Douglas, IS; Hite, RD; Hough, CL; Liu, KD; Matthay, MA; Rock, P; Shanholtz, C; Steingrub, J; Thompson, BT; Truwit, JD | 1 |
Burger, DM; de Kanter, CT; Keuter, M; Koopmans, PP; van der Lee, MJ | 1 |
Anzalone, D; Cain, VA; Cressman, MD; Shepherd, J; Stein, EA; Vidt, DG | 1 |
Chen, PZ; Feng, Y; Kang, L; Liu, M; Liu, YZ; Wang, ZF; Zhang, YM; Zheng, JH | 1 |
Ault, A | 1 |
Wolfe, SM | 1 |
Alsheikh-Ali, AA; Ambrose, MS; Karas, RH; Kuvin, JT | 1 |
1 review(s) available for fluorobenzenes and Renal Insufficiency
Article | Year |
---|---|
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.
Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol, LDL; Clinical Trials as Topic; Evidence-Based Medicine; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2012 |
1 trial(s) available for fluorobenzenes and Renal Insufficiency
Article | Year |
---|---|
Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Female; Fluorobenzenes; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Sulfonamides; Survival Analysis; Treatment Failure | 2014 |
5 other study(ies) available for fluorobenzenes and Renal Insufficiency
Article | Year |
---|---|
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Dyslipidemias; Fluorobenzenes; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lopinavir; Male; Middle Aged; Pyrimidines; Pyrimidinones; Renal Insufficiency; Rhabdomyolysis; Ritonavir; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2011 |
Protective effects of rosuvastatin in experimental renal failure rats via improved endothelial function.
Topics: Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2013 |
Pressure group urges rosuvastatin recall.
Topics: Adult; Advisory Committees; Drug and Narcotic Control; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration | 2004 |
Dangers of rosuvastatin identified before and after FDA approval.
Topics: Drug Approval; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pyrimidines; Renal Insufficiency; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration | 2004 |
The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.
Topics: Consumer Product Safety; Drug Evaluation; Drug Prescriptions; Fluorobenzenes; Humans; Kidney Diseases; Morbidity; Product Surveillance, Postmarketing; Proteinuria; Pyridines; Pyrimidines; Renal Insufficiency; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2005 |